Feldamycic acid, having the structure ##STR1## is obtained by the hydrolysis of the antibiotic feldamycin (U-48,266) and can be coupled with nutritional amino acids to give peptides, useful as nutritional supplements.

Vinblastine, vincristine and leurosidine are converted to 3-carboxylic acids and 4-desacetyl-3-carboxylic acids, useful as intermediates to prepare aliphatic esters thereof.

Descarboxylysergic acid prepared from 2,3-dihydro-8.beta.-hydroxy-6-methyl-9-ergolene or from penniclavine has oxytocic, serotonin antagonist, prolactin inhibition and muscle contracting activities.

Hydroconversion processes for converting oil, coal or mixtures thereof are provided utilizing a catalyst prepared by first forming an aqueous solution of phosphomolybdic acid and phosphoric acid at a specified ratio of atoms of P/Mo, and subsequently adding this solution to a hydrocarbon material, followed by heating in the presence of H.sub.2 and/or H.sub.2 S to form a solid molybdenum and phosphorus-containing catalyst.

A process for the preparation of citric acid which comprises contacting an unsaturated compound selected from 3-methylene-1,5-pentanediol and its esters with a nitric acid solution in an amount of 2 to 50 mols of nitric acid feed per mol of unsaturated compound feed, and at least 0.005 mol percent nitrogen dioxide based on nitric acid, at a temperature between -10.degree. and 120.degree. C., to thereby oxidize said unsaturated compound to citric acid. Preferably the contacting of the unsaturated...

Process for oxidatively carbonylating toluene to toluic acid, at least 50 mol % of the toluic acid being the p-isomer, said process comprising contacting and reacting, at 110.degree.-250.degree. C., at a pressure of at least 500 psi (3.45 MPa), toluene, carbon monoxide, oxygen and the catalyst ingredients consisting essentially of (a) a compound of rhodium, iridium, ruthenium, platinum, palladium or osmium; (b) a sulfur oxy-acid or a Group Ia or IIa metal salt of a sulfur oxy-acid; and (c) an ac...

Process for oxidatively carbonylating toluene to toluic acid, at least 50 mol % of the toluic acid being the p-isomer, said process comprising contacting and reacting, at 110.degree.-250.degree. C., at a pressure of at least 500 psi (3.45 MPa), toluene, carbon monoxide, oxygen and the catalyst ingredients consisting essentially of (a) a compound of rhodium or iridium; (b) a sulfur oxy-acid or a Group Ia or IIa metal salt of a sulfur oxy-acid; (c) a sulfur oxy-acid or sulfur oxy-acid mixture havi...

Process for oxidatively carbonylating toluene to toluic acid, at least 50 mol % of the toluic acid being the p-isomer, said process comprising contacting and reacting, at 110.degree.-250.degree. C., at a pressure of at least 500 psi (3.45 MPa), toluene, carbon monoxide, oxygen and the catalyst ingredients consisting essentially of (a) a compound of rhodium, iridium, ruthenium, platinum, palladium or osmium; (b) a sulfur oxy-acid or a Group Ia or IIa metal salt of a sulfur oxy-acid; and (c) an ac...

A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrolysable ester thereof, wherein: ##STR00001##

A process for purifying phosphoric acid includes removing volatile components from phosphoric acid rich in impurities to form a crude phosphoric acid liquid substantially free of volatile components; heating the crude phosphoric acid liquid to a temperature above 250.degree. C. in order to decompose phosphoric acid in the crude phosphoric acid liquid and generate gaseous phosphoric anhydride; and introducing the gaseous phosphoric anhydride into water or a dilute phosphoric acid aqueous solution...